+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

AI in Epidemiology Market Outlook 2026-2034: by Deployment (Cloud-Based, Web-Based / on-Prem), End User, Application, AI Technology

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6244142
UP TO OFF until Jan 01st 2027
The AI In Epidemiology Market is estimated at US$1.2 billion in 2026 and is projected to grow at a CAGR of 27.5% to reach US$8.4 billion by 2034.

Market Overview

The AI In Epidemiology Market covers AI tools used to analyze population-health and disease-pattern data.

Data coverage and representativeness affect the reliability of findings; evaluation needs to account for changes in surveillance and reporting practices.

Market Segmentation

By Deployment

  • Cloud-Based
  • Web-Based / On-Prem

By End User

  • Pharmaceutical & Biotechnology Companies
  • Government & State Agencies
  • Research Institutes & Academia
  • Healthcare Providers

By Application

  • Infection Prediction & Forecasting
  • Disease & Syndromic Surveillance
  • Outbreak Early-Warning & Response Optimization
  • Antimicrobial-Resistance (AMR) Monitoring

By AI Technology

  • Machine-Learning (ML) Algorithms
  • Deep-Learning (DL) & Neural Networks
  • Large Language Models (LLMs)
  • Quantum & Hybrid Optimization

Key Companies Analysed

  • Palantir Technologies
  • IQVIA
  • Oracle
  • Microsoft
  • Google
  • SAS Institute
  • IBM
  • Databricks
  • Esri
  • BlueDot
  • Metabiota
  • Aetion
  • Thoughtworks
  • Kinsa
  • Health Catalyst
  • ArcGIS
  • Confluent
  • Snowflake
  • AWS
  • Epic Systems

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global AI In Epidemiology Market Overview
2.1. AI In Epidemiology Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. AI In Epidemiology Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. AI In Epidemiology Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global AI In Epidemiology Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
5.2. AI In Epidemiology Market Analysis By Deployment, 2025-2034
5.2.1. Cloud-Based
5.2.2. Web-Based / On-Prem
5.3. AI In Epidemiology Market Analysis By End User, 2025-2034
5.3.1. Pharmaceutical & Biotechnology Companies
5.3.2. Government & State Agencies
5.3.3. Research Institutes & Academia
5.3.4. Healthcare Providers
5.4. AI In Epidemiology Market Analysis By Application, 2025-2034
5.4.1. Infection Prediction & Forecasting
5.4.2. Disease & Syndromic Surveillance
5.4.3. Outbreak Early-Warning & Response Optimization
5.4.4. Antimicrobial-Resistance (AMR) Monitoring
5.5. AI In Epidemiology Market Analysis By AI Technology, 2025-2034
5.5.1. Machine-Learning (ML) Algorithms
5.5.2. Deep-Learning (DL) & Neural Networks
5.5.3. Large Language Models (LLMs)
5.5.4. Quantum & Hybrid Optimization
6. North America AI In Epidemiology Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America AI In Epidemiology Market Analysis By Deployment
6.3. North America AI In Epidemiology Market Analysis By End User
6.4. North America AI In Epidemiology Market Analysis By Application
6.5. North America AI In Epidemiology Market Analysis By AI Technology
6.6. North America Outlook By Country
6.6.1. United States
6.6.2. Canada
6.6.3. Mexico
7. Europe AI In Epidemiology Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe AI In Epidemiology Market Analysis By Deployment
7.3. Europe AI In Epidemiology Market Analysis By End User
7.4. Europe AI In Epidemiology Market Analysis By Application
7.5. Europe AI In Epidemiology Market Analysis By AI Technology
7.6. Europe Outlook By Country
7.6.1. Germany
7.6.2. United Kingdom
7.6.3. France
7.6.4. Italy
7.6.5. Spain
7.6.6. Netherlands
7.6.7. Switzerland
7.6.8. Poland
7.6.9. Sweden
7.6.10. Russia
8. Asia-Pacific AI In Epidemiology Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific AI In Epidemiology Market Analysis By Deployment
8.3. Asia-Pacific AI In Epidemiology Market Analysis By End User
8.4. Asia-Pacific AI In Epidemiology Market Analysis By Application
8.5. Asia-Pacific AI In Epidemiology Market Analysis By AI Technology
8.6. Asia-Pacific Outlook By Country
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Australia
8.6.6. Indonesia
8.6.7. Malaysia
8.6.8. Vietnam
9. Middle East and Africa AI In Epidemiology Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa AI In Epidemiology Market Analysis By Deployment
9.3. Middle East and Africa AI In Epidemiology Market Analysis By End User
9.4. Middle East and Africa AI In Epidemiology Market Analysis By Application
9.5. Middle East and Africa AI In Epidemiology Market Analysis By AI Technology
9.6. Middle East and Africa Outlook By Country
9.6.1. Saudi Arabia
9.6.2. South Africa
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Egypt
10. South and Central America AI In Epidemiology Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America AI In Epidemiology Market Analysis By Deployment
10.3. South and Central America AI In Epidemiology Market Analysis By End User
10.4. South and Central America AI In Epidemiology Market Analysis By Application
10.5. South and Central America AI In Epidemiology Market Analysis By AI Technology
10.6. South and Central America Outlook By Country
10.6.1. Brazil
10.6.2. Argentina
10.6.3. Chile
10.6.4. Peru
11. AI In Epidemiology Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Palantir Technologies
11.2.2. IQVIA
11.2.3. Oracle
11.2.4. Microsoft
11.2.5. Google
11.2.6. SAS Institute
11.2.7. IBM
11.2.8. Databricks
11.2.9. Esri
11.2.10. BlueDot
11.2.11. Metabiota
11.2.12. Aetion
11.2.13. Thoughtworks
11.2.14. Kinsa
11.2.15. Health Catalyst
11.2.16. ArcGIS
11.2.17. Confluent
11.2.18. Snowflake
11.2.19. AWS
11.2.20. Epic Systems
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Palantir Technologies
  • IQVIA
  • Oracle
  • Microsoft
  • Google
  • SAS Institute
  • IBM
  • Databricks
  • Esri
  • BlueDot
  • Metabiota
  • Aetion
  • Thoughtworks
  • Kinsa
  • Health Catalyst
  • ArcGIS
  • Confluent
  • Snowflake
  • AWS
  • Epic Systems

Table Information